ADI MOR, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Chemomab Therapeutics Ltd.

Filing Date Source Excerpt
2021-06-14 “Dr. Mor received her Ph.D. in immunology from Tel Aviv University in the Department of Neurobiochemistry in Israel.”
2022-01-05 “Dr. Mor received her Ph.D. in immunology from Tel Aviv University in the Department of Neurobiochemistry”.
2022-04-28 “Dr. Mor received her Ph.D. in immunology from Tel Aviv University... [and has] broad experience in designing, developing and patenting a novel class of monoclonal antibodies...”

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-10-07